SUBSCRIBE
SUBSCRIBE

Elutia

NEWS
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
 · 
1 min read
IN THE PRESS
Press Releases
Elutia to Participate in Upcoming Investor Conferences
September 4, 2024
 · 
1 min read
Press Releases
Elutia Announces Second Quarter 2024 Results
August 8, 2024
 · 
14 min read
Press Releases
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
August 1, 2024
 · 
2 min read
Press Releases
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024
 · 
1 min read
BioCapital
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
June 17, 2024
 · 
7 min read
Business
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 2, 2024
 · 
1 min read
Business
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
March 7, 2024
 · 
15 min read
Business
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
February 22, 2024
 · 
1 min read
BioCapital
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
December 18, 2023
 · 
6 min read
BioCapital
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
November 9, 2023
 · 
5 min read
Load More
JOBS